These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35404188)

  • 1. Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indication.
    He L; Ren Y; Chen H; Guinn D; Parashar D; Chen C; Yuan SS; Korostyshevskiy V; Beckman RA
    Stat Methods Med Res; 2022 Jul; 31(7):1207-1223. PubMed ID: 35404188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the family-wise error rate in multi-arm, multi-stage trials.
    Crouch LA; Dodd LE; Proschan MA
    Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical basket design for binary outcomes with control of family-wise error rate.
    Asano J; Sato H; Hirakawa A
    BMC Med Res Methodol; 2023 Feb; 23(1):52. PubMed ID: 36849940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal two-stage designs for exploratory basket trials.
    Zhou H; Liu F; Wu C; Rubin EH; Giranda VL; Chen C
    Contemp Clin Trials; 2019 Oct; 85():105807. PubMed ID: 31260789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints.
    He T; Liu R; Liu M; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):567-581. PubMed ID: 36000260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
    Kurland BF; Doot RK; Linden HM; Mankoff DA; Kinahan PE
    Clin Trials; 2013; 10(6):886-95. PubMed ID: 24169628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimal two-stage exploratory basket trial design with aggregated futility analysis.
    Jing N; Liu F; Wu CI; Zhou H; Chen C
    Contemp Clin Trials; 2022 May; 116():106741. PubMed ID: 35358718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker.
    Beckman RA; Antonijevic Z; Kalamegham R; Chen C
    Clin Pharmacol Ther; 2016 Dec; 100(6):617-625. PubMed ID: 27509351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of treatment effect in two-stage confirmatory oncology trials of personalized medicines.
    Li W; Chen C; Li X; Beckman RA
    Stat Med; 2017 May; 36(12):1843-1861. PubMed ID: 28303586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the efficiency of oncology basket trials using a Bayesian approach.
    Liu R; Liu Z; Ghadessi M; Vonk R
    Contemp Clin Trials; 2017 Dec; 63():67-72. PubMed ID: 28629993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible Bayesian subgroup analysis in early and confirmatory trials.
    Bunn V; Liu R; Lin J; Lin J
    Contemp Clin Trials; 2020 Nov; 98():106149. PubMed ID: 32942055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designs for adding a treatment arm to an ongoing clinical trial.
    Bennett M; Mander AP
    Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
    Wang X; Wei W
    Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.
    Collignon O; Gartner C; Haidich AB; James Hemmings R; Hofner B; Pétavy F; Posch M; Rantell K; Roes K; Schiel A
    Clin Pharmacol Ther; 2020 May; 107(5):1059-1067. PubMed ID: 32017052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian borrowing for basket trials with longitudinal outcomes.
    Whitehead LE; Sailer O; Witham MD; Wason JMS
    Stat Med; 2023 Jul; 42(16):2819-2840. PubMed ID: 37120858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
    Tang H; Foster NR; Grothey A; Ansell SM; Goldberg RM; Sargent DJ
    J Clin Oncol; 2010 Apr; 28(11):1936-41. PubMed ID: 20212253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.